Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

IABP in elective high-risk PCI may offer long-term benefit

A trend toward improved mortality at six months in patients with severe ischemic cardiomyopathy who received elective intra-aortic balloon pump (IABP) support during PCI appears to persist in a long-term analysis of the BCIS-1 trial. The five-year outcome results put in focus the need for longer-term follow-up for these devices, according the authors of an accompanying editorial.

FDA clears thrombectomy system

Rex Medical has received 510(k) clearance from the FDA for its Cleaner15 rotational thrombectomy system, with an indication for mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

EU approves Gore's updated Excluder AAA Endoprosthesis

W. L. Gore & Associates (Gore) has received CE Mark for the new lower profile 31 mm diameter trunk-ipsilateral leg and 32 mm aortic extender components of the Gore Excluder AAA Endoprosthesis for treatment of abdominal aortic aneurysms (AAAs).

Complications often precede CPR in surgical patients

A retrospective study of cardiac arrest and cardiopulmonary resuscitation (CPR) in surgical patients found that most arrests and resuscitations occurred postoperatively and after the patient developed complications. The results were published online in the January issue of the Journal of the American Medical Association-Surgery.

CoreValve, Sapien/Sapien XT demonstrate equal outcomes at 30 days, 1 year

There were no observed differences between the transcatheter aortic valve replacement (TAVR) Sapien/Sapien XT and CoreValve devices in an adjusted analysis in Valve Academic Research Consortium (VARC) outcomes, except for the need for permanent pacemakers with the CoreValve. The PRAGMATIC registry analysis was published online Jan. 16 in the Journal of the American College of Cardiology.

EU clears St. Jude's updated Amplatzer occluder

St. Jude Medical has received European CE Mark approval of its Amplatzer Amulet left atrial appendage (LAA) occluder device, which is used to close the LAA in patients diagnosed with nonvalvular atrial fibrillation.

EU body recommends suspending Tredaptive

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) confirmed recommending suspension of the marketing authorizations of Merck’s Tredaptive, Pelzont and Trevaclyn (nicotinic acid/laropiprant) used to treat adults with dyslipidemia. 

Pooled blood plasma product OK’d in U.S.

The FDA has approved Octaplas, a pooled human plasma blood product for the replacement of coagulation factors in certain medical conditions where patients have insufficient levels.

Displaying 8401 - 8408 of 10761

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.